Genoox, a genetic data analysis company, recently partnered with Bionano Genomics to better identify the nearly 20k potentially disease-causing SVs in the human genome. By combining Genoox technology and Bionano mapping data, the new Genoox integrated platform will offer clinicians a single platform for accurate detection of genetic mutations for rare disease. Genoox and Bionano intend to co-sell and co-market the integrated platform for research and future clinical applications.Children’s
Read More
- Skip to main content
- Skip to secondary menu
- Skip to primary sidebar
- Skip to secondary sidebar
- Skip to footer
Footer
